When might pharmacotherapy or bariatric options be considered in pediatric obesity?

• A. For all children with obesity
• B. Only after lifestyle changes fail in toddlers
• C. In adolescents when appropriate, under medical supervision
• D. Never, as not approved for youths

Answer: (C)

The concept here is that medications or surgical options for obesity in kids are not used for every child. They’re considered for adolescents who have severe obesity and who haven’t achieved meaningful weight loss with intensive lifestyle changes, especially when there are obesity-related health risks. Because these treatments carry safety, growth, and long-term follow-up considerations, they must be used under close medical supervision with a multidisciplinary team.

In practice, this means selecting teens who are appropriate candidates, ensuring there’s readiness and support for ongoing monitoring, and using therapies that have approved indications for youths. Pharmacotherapy may be considered with age-approved medications and careful monitoring of growth, side effects, and comorbidities. Bariatric surgery is reserved for select adolescents with very high BMI and significant health risks, following thorough evaluation and commitment to lifelong follow-up.

This approach explains why the best choice is that pharmacotherapy or bariatric options can be considered in adolescents when appropriate, under medical supervision.